Tristel Company Description

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.

It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems.

The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.

Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Tristel plc

Country	United Kingdom
Founded	1993
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	233
CEO	Matthew Sassone

Contact Details

Address: Lynx Business Park Snailwell, CB8 7NY United Kingdom
Phone	44 16 3872 1500
Website	tristel.com

Stock Details

Ticker Symbol	TSTL
Exchange	London Stock Exchange AIM
Fiscal Year	July - June
Reporting Currency	GBP
ISIN Number	GB00B07RVT99
SIC Code	2840

Key Executives

Name	Position
Matthew Sassone	Chief Executive Officer
Elizabeth Dixon	Chief Financial Officer